Sign In | Join Free | My vivirlatino.com
vivirlatino.com
Hongkong Kangdisen Medical Co., Limited
Hongkong Kangdisen Medical Co., Limited Serve People's Health
Home > Nicotinamide Riboside NR >

HGH 176-191 HGH Peptide Growth Hormone Releasing Factor 66004-57-7

Hongkong Kangdisen Medical Co., Limited
Trust Seal
Verified Supplier
Credit Check
Supplier Assessment

HGH 176-191 HGH Peptide Growth Hormone Releasing Factor 66004-57-7

Brand Name : KANGDISEN
Model Number : 2 mg/vial
Certification : GMP
Place of Origin : China
MOQ : negotiatable
Price : negotiatable
Payment Terms : MoneyGram, T/T, Bitcoin
Supply Ability : 100,000 vials each month
Delivery Time : 3 days
Packaging Details : 10 vials/kit
Product Name : Fragment 176-191
Molecular Formula : C78H125N23O23S2
Synonyms : HGH Frag 176-191
Sequence : H-Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-OH
Purity : >98%
CAS : 66004-57-7
Contact Now

HGH 176-191 HGH Peptide Growth Hormone Releasing Factor 66004-57-7


We can supply HGH Fragment 176-191, 2 mg/vial.


Reduces the most stubborn abdominal fat.


- Increases muscle mass.
- Increases IGF-1 levels, in an effective manner, thus making this a peptide that burns fat and exhibits anabolic function.
- Increases energy expenditure.
- Improves lipid profiles and lipolytic activity.
- Does not negatively impact blood glucose level, nor does cell proliferation occur, like Human Growth Hormone.

- Extremely potent and effective fat burner.


This peptide comes in 2mg aliquots or 5mg/vial, regardless of the amount ordered.


FOR A DETAILED ANALYSIS PLEASE SEE THE BELOW ARTICE AND VIEW THE REFERENCED SOURCES:


The (HGH fragment 176-191) is a stabilized analogue of the growth hormone-releasing factor (GRF) that induces growth hormone (GH) in a specific and physiological manner. To date studies suggest that (HGH fragment 176-191) has several beneficial features: it reduces abdominal fat (in particular visceral fat), without compromising glycemic control (blood glucose), it increases muscle mass and improves the lipid profile. These characteristics make it an ideal candidate for the treatment of excess abdominal fat, an important aspect of HIV-associated lipodystrophy.


At a dosage of 500mcg the (HGH fragment 176-191) was shown to increase lipolytic activity in adipose tissue. In other words this fragment potently burns body fat, especially stubborn adipose body fat, and it does so potently! Of significance, is that the fragment has no negative impact on insulin sensitivity, a stark contrast from its Human Growth Hormone counterpart.(Ng FM, Sun J,Sharma L, Libinaka R, Jiang WJ, and Gianello R 2000).


Not only does the (HGH fragment 176-191) not interfere with the body’s natural insulin regulation as Human Growth Hormone can, the (HGH fragment 176-191) does not result in cellular proliferation as Human Growth Hormone does. The fragment is similar to Human Growth Hormone, hence the shared amino acid sequence, however, the (HGH fragment 176-191) does not induce hyperglycaemia or reduce insulin secretion.


The (HGH fragment 176-191) does not compete for the hGH receptor and nor does it induce cell proliferation, unlike Human Growth Hormone. (Wu Z, Ng FM. 1993). Thusly, this is a very beneficial peptide in terms of burning fat, without unwanted and undesirable side effects. Of particular note is the fragments ability to increase IGF-1 levels which translate into the fragments ability to give collateral anti-aging and anabolic effects along with its ability to induce lipplytic (fat burning) activity.


In yet another study, the (HGH fragment 176-191) exhibits the ability to burn through adipose tissue by increasing lipolytic activity (the breakdown of fat) , in the most stubborn body fat (adipose tissue) while increasing energy expenditure and glucose and fat oxidation in ob/ob mice treated with (HGH fragment 176-191). In addition, (HGH fragment 176-191) increased in vitro lipolytic activity and decreased lipogenic activity in isolated adipose tissue from obese rodents and humans.(Heffernan MA, Jiang WJ, Thorburn AW, Ng FM. 2000).


Thusly, the (HGH fragment 176-191) exhibits the ability to burn through stubborn adipose tissue, while increasing energy expenditure, muscle mass, and fat oxidation. All studies have pointed to the fact that the fragment is an effective treatment for obesity and fat loss, and much safer than its Human Growth Hormone counterpart.


RESEARCH DOSAGE:


- 500mcg-2mg every day


STORAGE:


- REFRGIRATE UPON RECEIPT.


KEEP REFRIGERATED AFTER RECONSTITUTION ALLOW 24 HOURS FOR THE PEPTIDE TO SETTLE BEFORE BEGINNING YOUR RESEARCH.


More information about Hgh Fragment (176-191)


Growth Hormone peptide fragment 176-191, also known as HGH Frag 176-191, is a modified form of amino acids 176-191 of the GH polypeptide. Investigators at Monash University discovered that the fat-reducing effects of GH appear to be controlled by a small region near one end of the Growth Hormone molecule. This region, which consists of amino acids 176-191, is less than 10% of the total size of the GH molecule and appears to have no effect on growth or insulin resistance.


It works by mimicking the way natural Growth Hormone regulates fat metabolism but without the adverse effects on blood sugar or growth that is seen with unmodified Growth Hormone. Like Growth Hormone, the hgH fragment 176-191 stimulates lipolysis (the breakdown or destruction of fat) and inhibits lipogenesis (the transformation of nonfat food materials into body fat) both in laboratory testing and in animals and humans.


Laboratory Tests and Fat Loss


In laboratory tests on fat cells from rodents, pigs, dogs, and humans, the hgH fragment released fat specifically from obese fat cells but not from lean ones, reduced new fat accumulation in all fat cells, enhanced the burning of fat. In rodents (rats and mice), hgH fragment reduced body fat in obese animals but, enhanced fat burning without changing food consumption or inducing growth (as it does not increase IGF levels) or any other unwanted Growth Hormone effect. Research dosages of 500mcg of the hgH fragment 176-191 daily for 30 days did show a reduction of body fat in the mid abdominal area in both obese, over-weight, and average built people.


Fragment 176-191 as an Active HGH Truncated Peptide


hgH fragment 176-191 is an analog of the growth hormone-releasing factor (GRF) which signals the effects of growth hormone. It is a 15-mer peptide residue of the C-terminus of HGH to which tyrosine is added at the N-terminal end. This synthetically produced hormone is very common to weightlifters and bodybuilders because of a number of physical benefits. Studies claimed that it actually acts on the reduction of excessive adipose tissues such as those in the abdominal area, increase in muscle mass, and enhances the lipid content of the body.


These segments of the synthetic peptide hgH 176-191 have been investigated for their in vivo effects in laboratory mice musculus. Research results have shown that hgH 176-191 have resulted to a short-period increase in blood glucose and a more sustained increase in plasma insulin, together with other fragments such as 172-191, 177-191 and 178-191. In addition, the researchers have suggested that functionality of the peptide depends not only in the informational sequence but should also have the correct physical configuration (Ng and Borstein 1978).


Also, this fragment, being a region of high accessibility to proteases and also rich in proline, have been demonstrated to affect the conformational change in the cytoplasmic domain of the band 3 of erythrocyte membrane protein by serving as the hinge for the pivoting of the two subdomains. This then suggest that such residue is significant in conformational changes be serving as sites for peripheral protein binding in some body cells (Low et al. 1984).


In another study of Ng et al. (2000) on animal subjects, they found out that a 500mcg dosage of the said hormone increased the lipolytic activity in adipose tissues without having negative influence in the blood glucose level. Furthermore, though it behaves like a human growth hormone (hgH), it does not causes hyperglycemia because it does not compete with hgH receptors (Wu et al. 1993). Because of such effects, researchers have suggested that it might be used for the elimination of excess abdominal fat which is a significant aspect of HIV-associated lipodystrophy.


The (hgH fragment 176-191) exhibits the ability to burn through stubborn adipose tissue, while increasing energy expenditure, muscle mass, and fat oxidation. All studies have pointed to the fact that the fragment is an effective treatment for obesity and fat loss, and much safer than its Human Growth Hormone counterpart.


(Please NOTE: It is normal for FRAGMENT (176-191) to mix cloudy after reconstitution with bacteriostatic water.)


Product Tags:

nicotinamide riboside supplement

      

nicotinamide riboside synthesis

      
China Customized Inflatable Bumper Ball Game Bubble Adult Grass CE supplier

HGH 176-191 HGH Peptide Growth Hormone Releasing Factor 66004-57-7 Images

Inquiry Cart 0
Send your message to this supplier
 
From:
Enter your email please.
To: Hongkong Kangdisen Medical Co., Limited
Subject:
Message:
Characters Remaining: (0/3000)
 
Inquiry Cart 0